GlassScriptPhysician profile
Polly F Train
NPI 1659492916
$14,079.00
in general payments reported to CMS, 2019-2025
27 companies · $1,942 in 2025
The $1,942 reported for 2025 was more than what 94% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.36 · 2020: $93.83 · 2021: $349 · 2022: $290 · 2023: $11K · 2024: $377 · 2025: $1,942.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $12K · Food and Beverage: $1,185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $12,088.13 |
| Food and Beverage | $1,185.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,083.42 | 2023-2025 | Davinci Xi, Da Vinci Surgical System |
| Exeltis, USA INC. | $259.33 | 2021-2025 | Slynd |
| Astellas Pharma US INC | $252.40 | 2021-2025 | Veozah, Myrbetriq |
| Biogen, INC. | $199.79 | 2025 | Zurzuvae |
| Abbvie INC. | $170.45 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Pfizer INC. | $145.41 | 2019-2025 | |
| Agile Therapeutics, INC. | $109.40 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $106.06 | 2023-2025 | Myfembree |
| Therapeuticsmd, INC. | $99.56 | 2020-2022 | |
| Novo Nordisk INC | $93.91 | 2022-2024 | Wegovy |
| Hologic Sales and Service, LLC | $81.95 | 2023-2025 | Acessa Provu System, Novasure, Coolseal Generator |
| Bayer Healthcare Pharmaceuticals INC. | $80.04 | 2020-2025 | |
| Amgen INC. | $66.91 | 2022-2024 | Evenity, Prolia |
| Biohaven Pharmaceuticals, INC. | $45.67 | 2021 | |
| Coopersurgical, INC. | $44.92 | 2024-2025 | Paragard T 380a |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $36.96 | 2020-2021 | |
| Minerva Surgical, INC | $35.97 | 2022-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $26.00 | 2022 | |
| Organon LLC | $23.56 | 2022-2023 | Nexplanon |
| Scynexis, INC. | $20.44 | 2022 | |
| Radius Health, INC. | $16.11 | 2025 | Tymlos |
| Merck Sharp & Dohme LLC | $15.79 | 2020 | |
| Myovant Sciences INC. | $15.65 | 2022 | |
| Shield Therapeutics INC | $14.87 | 2025 | |
| Daiichi Sankyo INC. | $13.68 | 2021 | |
| Lupin INC. | $11.84 | 2020 | |
| Meditrina | $8.91 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Polly Train listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.